TP53 and hepatocellular carcinoma: Previous studies have reported that ketoconazole produce apoptosis inducing p53 levels and PARP cleavage in breast cancer cells [41], human colorectal and hepatocellular carcinoma cell lines [42]; therefore, a similar mechanism could be involved in the apoptosis of CML